Related Experiment Video
Updated: Apr 26, 2026
Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
Published on: March 24, 2023
Obesity, ostearthritis and clinical treatment
Andres de la Espriella Rosales1, Nadia Lucila Rocha Brito1, Renato Frucchi1
11. Institute of Orthopedics and Traumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil, 1. Institute of Orthopedics and Traumatology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil, Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas , Institute of Orthopedics and Traumatology, São Paulo, SP, Brazil.
Objective:
To evaluate the relationship between BMI and pain and function in patients with OA undergoing medical treatment following OARSI recommendations.
Methods:
Thirty-eight patients were classified according to their arthritis degree by X-ray and body mass index (BMI). All patients completed the WOMAC, Lequesne, and visual analogue pain scale (VAS) questionnaires at baseline and after six months treatment. All patients were treated with diacerhein and analgesics (according to pain), orthotics (when indicated), and an educational program on osteoarthritis. They were instructed on balanced diet and exercise at least three times a week.
Results:
There was no significant BMI variation in this study. The higher the initial BMI, the lower the improvement in pain (p = 0.03). Pain did not improve significantly (p = 0.2). Function improved (p <0.001) in inverse ratio to the initial BMI.
Conclusion:
BMI determines how patients will improve pain and function.
Related Concept Videos
01:24Obesity
01:21Drug Dosing: Obese Patients
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
01:26Atherosclerosis III: Management
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation